Comera Life Sciences Inc...

0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.09
44900.00%
After-hours: Nov 16, 2023, 07:58 PM EST

Comera Life Sciences Income Statement

Year FY22 FY21 FY20
Revenue 633.1K 319.83K 442.92K
Cost of Revenue 210.39K 161.01K 104.41K
Gross Profit 422.71K 158.82K 338.51K
Operating Income -11.97M -5.54M -2.13M
Interest Income n/a n/a n/a
Pretax Income -18M -5.45M -2.13M
Net Income -18M -5.29M -2.13M
Selling & General & Admin 10.65M 3.94M 1.2M
Research & Development 1.74M 1.75M 1.26M
Other Expenses n/a -76.74K 2.03K
Operating Expenses 12.39M 5.69M 2.47M
Interest Expense 20.39K n/a n/a
Selling & Marketing Expenses n/a n/a n/a
Cost & Expenses 12.6M 5.86M 2.57M
Income Tax n/a -160.59K -116.55K
Shares Outstanding (Basic) 10.45M 19.09M 19.09M
Shares Outstanding (Diluted) 10.45M 19.09M 19.09M
EPS (Basic) -1.76 -0.28 -0.11
EPS (Diluted) -1.76 -0.28 -0.11
EBITDA -17.89M -5.36M -2.04M
Depreciation & Amortization 93.95K 88.82K 89.75K